The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy. (2012)
Attributed to:
Molecular determinants of Radiosensitivity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.4161/cbt.21093
PubMed Identifier: 22825331
Publication URI: http://europepmc.org/abstract/MED/22825331
Type: Journal Article/Review
Volume: 13
Parent Publication: Cancer biology & therapy
Issue: 11
ISSN: 1538-4047